ImmunoChemistry Technologies, LLC (ICT) is a biotechnology company based in Bloomington, Minnesota, USA. ICT is a limited liability company (LLC) and is owned and managed by four partners:

Gary L. Johnson, President
Dr. Brian W. Lee, Vice President of R&D
Sally Hed, Vice President of Marketing & Operations
Carol Lee, Board Member
 

History

ICT was founded in 1994 and financed by the owners. Since then, ICT has grown into a profitable business with many employees. ICT started as contract laboratory focusing on custom immunoassay development services and selling ELISA products. In 1999, ICT expanded its product lines by developing detection reagents for cell death and related areas of basic research. Today we have over 30 distributors selling our products worldwide. From 2008-2010, ICT was awarded almost $2 million from the NIH for four grant projects to develop in vivo tracer biomarker reagents. ICT has also established several key collaborations with academic and corporate partners to further develop its in-house technology for in vivo detection. In 2010, ICT reinvested over half of its income into R&D.

Products, Services, & Research

ICT is one of the world's leading suppliers of unique in vivo and in vitro detection tools critical for discovering promising investigational medicines. ICT's fluorescent detection probes are used to assess apoptosis and cell death in cultured cells and living animals. ICT's specialty in vitro probes detect active caspases, cathepsins, serine proteases, cholinesterase enzymes, and assess mitochondrial health. ICT’s proprietary FLIVO probes are used in vivo to assess apoptosis in living animal research models.?FLIVO may be used to assess the efficacy of chemotherapy, to quantify neurodegeneration, and as an early detector of eye disease, among other applications. It may eventually be used to better manage disease and personalize treatment. 
FLIVO won LifeScience Alley's New Technology Showcase Award in Dec. 2008.

ICT's contract laboratory specializes in custom ELISA development, manufacturing, and testing services. As an out-growth of these services, ICT offers a specialty line of ELISA buffers and stabilizers for assay development and manufacturing.

ICT specializes in assays to detect intracellular proteases in whole living cells without using antibodies. 

  With our new FLICA™ , Magic Red™ , MitoPT™ , FLISP™ , Cholinesterase , and Cytotoxicity kits, researchers can now quantitate apoptosis and cytotoxicity by measuring active caspases, cathepsins, serine proteases, cholinesterase, and mitochondrial functionality in live, intact cells - no lysis or permeabilization steps are required. These unique kits are not ELISAs and do not use antibodies - instead they use fluorescent-labeled cell-permeant substrate and inhibitor peptide sequences specifically targeted by active protease enzymes.
  We initially founded our company in 1994 as a service laboratory doingcustom immunoassay development . Through our experience developing assays, we began to sell our secret ELISA buffers as stand-alone products to researchers making their own tests. This also lead to the development of ourwhole-cell protease kits (which are not ELISAs). (This is why our name is Immunochemistry Technologies (ICT), and our logo looks like an antibody, even though our protease kits do not use antibodies!).

上海聚仕隆生物致力于提供科研試劑、耗材、儀器等產(chǎn)品的一站式采購方案

上海聚仕隆生物科技有限公司

：4000867886

：李

:http://www.joslong.cn/

地址：上海市松江區(qū)松匯西路1606-2號

世界ICT正式*上海聚仕隆生物科技有限公司為其代理，ICT 一直為廣大科研客戶提供zui為優(yōu)質(zhì)的產(chǎn)品和服務(wù)；上海聚仕隆自成立以來始終堅持為中國科研客戶帶來的產(chǎn)品和體驗，ICT產(chǎn)品的加入*地豐富了我們的產(chǎn)品數(shù)量和類別，提供更好的一站式采購體驗。ICT 中國代理，ICT上海代理，ICT北京代理，ICT廣東代理，ICT天津代理，ICT重慶代理，ICT江蘇代理， ICT浙江代理，ICT福建代理，ICT 浙江代理， ICT 黑龍江代理， ICT內(nèi)蒙古代理，ICT吉林代理，ICT江蘇代理， ICT 四川代理，ICT 廣西代理，ICT 江西代理，ICT陜西代理，ICT 山西代理，ICT 安徽代理，ICT 西安代理，ICT武漢代理